These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6097918)

  • 1. Facilitatory effects of monoamine synthesis inhibitors on lysine-vasopressin induced changes in the exploratory behaviour pattern of male rats.
    Höglund AU; Meyerson BJ
    Pharmacol Biochem Behav; 1984 Dec; 21(6):859-63. PubMed ID: 6097918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lysine-vasopressin in an exploratory behaviour test situation.
    Höglund AU; Meyerson BJ
    Physiol Behav; 1982 Aug; 29(2):189-93. PubMed ID: 7146123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilocarpine-induced purposeless chewing behaviour in rats is dependent on intact central stores of 5-HT.
    Stewart B; Rose S; Jenner P; Marsden CD
    Eur J Pharmacol; 1987 Oct; 142(1):173-6. PubMed ID: 2961579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine and 5,7-dihydroxytryptamine on the hippocampal kindling effect in rats.
    Araki H; Aihara H; Watanabe S; Yamamoto T; Ueki S
    Jpn J Pharmacol; 1983 Dec; 33(6):1177-82. PubMed ID: 6230476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine-vasopressin and lysine-vasopressin have different effects on spontaneous behaviour of rats.
    Tendis S; Klingberg F; Schaeker W
    Biomed Biochim Acta; 1987; 46(10):719-25. PubMed ID: 3446200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of indalpine--a selective inhibitor of 5-HT uptake--on rat paradoxical sleep.
    Kafi-De St Hilaire S; Merica H; Gaillard JM
    Eur J Pharmacol; 1984 Mar; 98(3-4):413-8. PubMed ID: 6233163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of physical dependence on barbiturates and cerebral monoamines.
    Tagashira E; Hiramori T; Urano T; Yanaura S
    Jpn J Pharmacol; 1983 Apr; 33(2):415-22. PubMed ID: 6193305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of a serotonergic control in the regulation of plasma levels of immunoreactive beta-endorphin.
    Cancela LM; Fulginiti S; Ramírez OA
    Acta Physiol Pharmacol Latinoam; 1985; 35(4):409-13. PubMed ID: 2872772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of monoamines in the behavioural effects of kainic acid in rats.
    Lenicque PM; Wepierre J; Cohen Y
    J Neural Transm; 1981; 51(3-4):205-12. PubMed ID: 6116744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential activity of enantiomers of amphetamine in rats.
    Maickel RP; Light KE; Zabik JE
    Neuropharmacology; 1982 Dec; 21(12):1323-7. PubMed ID: 6218425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of vasopressin on open-field activity and passive avoidance behaviour following intracerebroventricular versus intracisternal administration in rats.
    Günther O; Kovács GL; Szabó G; Schwarzberg H; Telegdy G
    Acta Physiol Hung; 1988; 71(2):203-6. PubMed ID: 3389163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment.
    Martin-Iverson MT; Yamada N; By AW; Lodge BA
    J Psychiatry Neurosci; 1991 Dec; 16(5):253-61. PubMed ID: 1686728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased investigative activity after presynaptic dopaminergic stimulation measured by a fixed-interval recording procedure.
    Höglund AU; Meyerson BJ
    Pharmacol Biochem Behav; 1985 Mar; 22(3):403-6. PubMed ID: 2859606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central serotonin neurones in avoidance learning: interactions with noradrenaline and dopamine neurones.
    Ogren SO
    Pharmacol Biochem Behav; 1985 Jul; 23(1):107-23. PubMed ID: 2994116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long lasting supersensitivity to 5-HT mediated behaviour following monoamine depletion in the rat brain.
    Rényi L
    Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):298-302. PubMed ID: 2948371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoaminergic mechanism of electroacupuncture analgesia.
    Cheng RS; Pomeranz B
    Brain Res; 1981 Jun; 215(1-2):77-92. PubMed ID: 6114781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamines and the mechanisms of action of antitussive drugs in rats.
    Kamei J; Ogawa M; Kasuya Y
    Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):117-27. PubMed ID: 2965557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamines as mediators of the antinociceptive effect of baclofen.
    Sawynok J
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jun; 323(1):54-7. PubMed ID: 6877393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoaminergic control of episodic growth hormone secretion in the rat: effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine, and haloperidol.
    Edén S; Bolle P; Modigh K
    Endocrinology; 1979 Aug; 105(2):523-9. PubMed ID: 156637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of different amphetamines on copulatory behaviour and stereotype activity in the female rat, after treatment with monoamine depletors and synthesis inhibitors.
    Michanek A; Meyerson BJ
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):301-12. PubMed ID: 145834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.